https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Budget impact analysis of increasing prescription of renin-angiotensin system inhibitors drugs to standard anti-hypertensive treatments in patients with diabetes and hypertension in a hypothetical cohort of Malaysian population https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36659 Wed 10 Nov 2021 15:14:22 AEDT ]]> Cost-effectiveness of bisphosphonates for prevention of fracture related to glucocorticoid-induced osteoporosis in Malaysia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:43137 Tue 13 Sep 2022 15:14:32 AEST ]]> Meta-analyses of newer antiepileptic drugs as adjunct for treatment of focal epilepsy in children https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:33760 50% seizure reduction, and a trend of better seizure freedom. Their tolerability would also be considered acceptable with the observed low withdrawal rate. However, the relative lack of well-conducted RCTs evaluating their effectiveness against other active AED treatment in children would not facilitate evidence-based practice. This highlights the knowledge gap and the need for more well-conducted RCTs against active treatments to ascertain the long term effectiveness and the role of newer AEDs in managing epilepsy in children.]]> Tue 03 Sep 2019 17:57:39 AEST ]]>